SCHEMBL3135467

SCHEMBL3135467

Cn1c(=O)c(-c2ccc(Br)cc2)cc2c3cc(C(=O)S)ccc3n(C)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.36
▸ GAA P10253 1/20 0.35
▸ CXCR3 P49682 2/20 0.34
▸ BRD4 O60885 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ BRPF1 P55201 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ MAPT P10636 3/20 0.32
▸ PGR P06401 1/20 0.32
▸ NR1H3 Q13133 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.31
▸ PPARG P37231 2/20 0.31
▸ EGFR P00533 1/20 0.31
▸ SRC P12931 1/20 0.31
▸ MCL1 Q07820 1/20 0.31
▸ NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1338146 0.89 MEN1 (0.39) KMT2AMEN1ATMKDM4EGAA
SCHEMBL1338964 0.86 GSK3B (0.41) KMT2AMEN1ATMKDM4EGAA
SCHEMBL3135471 0.86 KMT2A (0.36) KMT2AMEN1ATMKDM4EGAA
SCHEMBL1339068 0.85 MEN1 (0.36) KMT2AMEN1ATMKDM4EGAA
SCHEMBL1339139 0.82 LMNA (0.49) KMT2AMEN1ATMKDM4EGAA
SCHEMBL1339137 0.82 LMNA (0.49) KMT2AMEN1ATMKDM4EGAA
SCHEMBL1336807 0.79 ALDH1A1 (0.40) KMT2AMEN1ATMKDM4EGAA
SCHEMBL1339328 0.79 KMT2A (0.34) KMT2AMEN1ATMGAACXCR3
SCHEMBL1339132 0.79 HSD17B10 (0.46) KMT2AMEN1KDM4EGAACXCR3
SCHEMBL3569292 0.78 KDM4E (0.58) KMT2AKDM4EALDH1A1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940840-B1 6-HETEROARYLPYRIDOINDOLONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2010-07-21 — — EP disclosed
EP-1940840-A1 6-HETEROARYLPYRIDOINDOLONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2008-07-09 — — EP disclosed
WO-2007045758-A1 6-HETEROARYLPYRIDOINDOLONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2007-04-26 — — WO disclosed
Send feedback